Back to search

King Oyster, Eryngii · 2007 · Patent

High relevance

ENDO-BIOPOLYMERS PRODUCED FROM A SUBMERGED MYCELLIM CULTURE OF PLEUROTUS ERYNGII HAVING ANTITUMOR EFFECTS

Pleurotus eryngii

OncologyImmune supportMetabolic healthLiver support
SpeciesKing Oyster, Eryngii
JournalNot listed
Year2007

Key points

  • Endo-biopolymers produced from submerged mycelium culture of Pleurotus eryngii are provided to inhibit proliferation of tumor cancer cells, increase activity of natural killer(NK) cells in the spleen and activity of glutathione S-transferase in the liver
  • The endo-biopolymers produced from submerged mycelium culture of Pleurotus eryngii, having antitumor activity are provided, wherein the endo-biopolymers are composed of 77.5% of carbohydrates and 21.6% of proteins, and contain glucose and mannoses as major sugars, and glycine and aspartic acid as major amino acids
  • An anti-tumor agent contains the endo-biopolymers as effective ingredient

From the paper

Abstract

Endo-biopolymers produced from submerged mycelium culture of Pleurotus eryngii are provided to inhibit proliferation of tumor cancer cells, increase activity of natural killer(NK) cells in the spleen and activity of glutathione S-transferase in the liver. The endo-biopolymers produced from submerged mycelium culture of Pleurotus eryngii, having antitumor activity are provided, wherein the endo-biopolymers are composed of 77.5% of carbohydrates and 21.6% of proteins, and contain glucose and mannoses as major sugars, and glycine and aspartic acid as major amino acids. An anti-tumor agent contains the endo-biopolymers as effective ingredient.

Citation

SONG CHI HYUN, YANG BYUNG KEUN, LIM SANG KYU, JEONG YONG TAE (2007). ENDO-BIOPOLYMERS PRODUCED FROM A SUBMERGED MYCELLIM CULTURE OF PLEUROTUS ERYNGII HAVING ANTITUMOR EFFECTS.

Open citation